Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. read more
Amicus Therapeutics CEO & Leadership Team Ratings
John Crowley and the Amicus Therapeutics leadership team are scored a "C+" by 3 employees placing it in the Top 50% of companies sized 51-200 Employees on Comparably. The Leadership Score of 75/100 is based on 8 ratings; it combines employee feedback on their CEO (67/100), Manager (83/100), and Executive Team (90/100).
John Crowley Amicus Therapeutics CEO Rating
Bottom 40% Compared to other companies of similar size in New YorkC
67 / 100
John Crowley the CEO of Amicus Therapeutics received an average score of 67 from Amicus Therapeutics employees.Amicus Therapeutics Manager Rating
Top 20% Compared to other companies of similar size in New YorkB+
83 / 100
Amicus Therapeutics Executive Team Rating
Top 5% Compared to other companies of similar size in New YorkA+
90 / 100
×